Grabar Law Office Investigates Shareholder Claims for Major Companies
Philadelphia, Wednesday, 26 November 2025.
On November 26, 2025, Grabar Law Office began investigating potential shareholder claims for companies like Cytokinetics and Fortrea, focusing on corporate governance and possible fiduciary breaches.
Cytokinetics, Inc. Under Investigation
Grabar Law Office has launched an investigation into Cytokinetics, Inc. (NASDAQ: CYTK) concerning potential breaches of fiduciary duties by its officers and directors. The investigation focuses on allegations that the company made materially false and misleading statements regarding its New Drug Application (NDA) for aficamten. Notably, the U.S. Food and Drug Administration (FDA) chose not to convene an advisory committee meeting for the NDA, and the Prescription Drug User Fee Act action date was extended to December 26, 2025, due to the late submission of a Risk Evaluation and Mitigation Strategy (REMS) [1].
Fortrea Holdings, Inc. Faces Similar Scrutiny
Grabar Law Office is also investigating Fortrea Holdings, Inc. (NASDAQ: FTRE) for possible fiduciary breaches. The allegations include claims that Fortrea overstated potential revenue from pre-spin projects and exaggerated cost savings following the termination of certain service agreements. These actions are believed to have inflated the company’s earnings targets for 2025 and misrepresented its business prospects [1].
Inspire Medical Systems, Inc. Under the Microscope
The investigation extends to Inspire Medical Systems, Inc. (NYSE: INSP), focusing on securities fraud allegations. It is claimed that the company, through its officers, misled investors about the successful launch of its new sleep apnea device, ‘Inspire V’. Allegations suggest that the company falsely assured stakeholders of meeting all regulatory requirements and exaggerated demand for the product [1].
WEBTOON Entertainment Inc.’s Legal Challenges
Lastly, WEBTOON Entertainment Inc. (NASDAQ: WBTN) is under investigation for potential corporate governance issues. A lawsuit alleges that WEBTOON’s IPO Registration Statement contained misleading information about the company’s Monthly Active Users (MAUs), which were reportedly declining. The court has allowed the securities fraud class action complaint against WEBTOON to proceed, citing adequately alleged misrepresentations in the company’s disclosures [1].